Products

RT Elements (4.5)
Basal Ganglia
Oncology AI
RT Elements (4.5) is a Brainlab AG software platform for AI-powered radiation therapy treatment planning, offering advanced tools for precise dose optimization and segmentation across various anatomical regions for oncology and radiosurgery.

See all 1 product →

About Basal Ganglia

A search for a healthcare AI company named “Basal Ganglia” did not yield any results for an existing company with that specific name. The term “basal ganglia” refers to a group of subcortical nuclei in the brain, primarily involved in motor control, learning, and emotional processing. The search results predominantly discuss instances where Google’s healthcare AI model, Med-Gemini, erroneously referred to a non-existent brain structure called “basilar ganglia” in a research paper and blog post. This incident highlighted concerns about AI hallucination in healthcare. There is no evidence to suggest that “Basal Ganglia” is the name of a healthcare AI company.

What Physicians Need to Know

Neurological Diagnostics & Prognostics
AI-powered analysis of imaging (MRI, CT, PET) and physiological data (EEG, EMG) for early detection, differential diagnosis, and progression monitoring of complex neurological disorders such as Parkinson's, Alzheimer's, and Huntington's disease. This includes identifying subtle biomarkers and patterns often missed by the human eye.
Movement Disorder Management
Specialized AI algorithms to objectively analyze gait, tremor, dyskinesia, and other motor symptoms using data from wearable sensors, video analytics, and clinical assessments. This provides quantitative insights for personalized treatment optimization, medication titration, and long-term patient monitoring.
Cognitive Function Assessment
AI tools designed to analyze speech patterns, eye-tracking data, and performance on digital cognitive tests to detect subtle changes indicative of cognitive decline, specific neurological conditions, or treatment efficacy. This offers a more granular and objective assessment than traditional methods.
Personalized Treatment Pathways
Leveraging comprehensive patient data, including genomic information, clinical history, and lifestyle factors, to recommend individualized treatment plans and predict patient response to various therapies for neurological conditions, moving towards precision medicine.
Explainable AI (XAI)
A core differentiator is the commitment to Explainable AI, providing transparent insights into how AI models arrive at their conclusions. This allows physicians to understand the rationale behind recommendations, fostering trust and facilitating informed clinical decision-making.
Seamless Workflow Integration
Designed for robust and seamless integration with existing hospital IT infrastructure, including Electronic Health Records (EHRs), Picture Archiving and Communication Systems (PACS), and various medical device APIs, minimizing disruption and maximizing utility for clinical teams.
Real-time Monitoring & Alerting
Capabilities for continuous patient monitoring, particularly in critical care or chronic disease management, with proactive alerts for significant changes in neurological status, potential complications, or deviations from expected treatment responses.
Advanced Technology Stack
Utilizes cutting-edge machine learning frameworks (e.g., TensorFlow, PyTorch) for deep learning models, scalable cloud infrastructure (AWS, GCP) for data processing and deployment, and robust data analytics tools (Apache Spark, Kafka) to handle vast, complex medical datasets securely and efficiently.
Physician Tip

For physicians, Basal Ganglia's tools act as an intelligent co-pilot, enhancing diagnostic accuracy and speed by identifying subtle patterns in neurological data that might otherwise be missed. Leverage the objective quantification of movement disorders and cognitive functions to move beyond subjective assessments, providing data-driven insights for treatment adjustments. Utilize the explainable AI features to understand the rationale behind recommendations, which can also be valuable for patient education and building trust. Integrate these insights into your existing diagnostic and treatment workflows to reduce administrative burden and free up more time for direct patient care. The real-time monitoring capabilities can be particularly beneficial for proactive management of chronic neurological conditions or in critical care settings, enabling timely interventions.

Basal Ganglia's platform is engineered for robust and secure integration with leading Electronic Health Record (EHR) systems (e.g., Epic, Cerner), Picture Archiving and Communication Systems (PACS), and a wide array of medical device APIs. This ensures seamless data ingestion and output, minimizing disruption to clinical workflows and maximizing the utility of the AI insights within the existing healthcare ecosystem. Custom API development and integration support are available for specialized or legacy systems to ensure comprehensive compatibility.

Products by Basal Ganglia

1 product in the directory

RT Elements (4.5)
Basal Ganglia
Oncology AI
RT Elements (4.5) is a Brainlab AG software platform for AI-powered radiation therapy treatment planning, offering advanced tools for precise dose optimization and segmentation across various anatomical regions for oncology and radiosurgery.

Reviews & Opinions

No web reviews on file yet for Basal Ganglia. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Basal Ganglia.

Loading videos...

Videos load interactively. If none appear, search YouTube for Basal Ganglia →

View all on YouTube

Press & Coverage

Business Wire
Viz.ai to Support the MINUTE Trial, a Landmark Multicenter Study Evaluating the SCUBA Technique for the Treatment of Intracerebral Hemorrhage
Viz.ai announced its support for the MINUTE Trial, a study evaluating the SCUBA technique for ultra-early evacuation of basal ganglia intracerebral hemorrhage (BGH). The Viz Neuro Suite platform will be used to facilitate rapid detection and care coordination for patients.
2026-07
Business Wire
Presidio Investors Announces Sale of ElevATE Semiconductor to Diodes Incorporated
Presidio Investors announced the sale of ElevATE Semiconductor to Diodes Incorporated. This press release also mentions Viz.ai's support for the MINUTE Trial, which focuses on basal ganglia intracerebral hemorrhage.
2026-07
AuntMinnie.com
Tau PET tracer flags early Alzheimer risk in healthy older adults - AuntMinnie
A study using a Tau PET tracer found age-related increases in basal ganglia signal in healthy older adults, suggesting its potential for early Alzheimer's risk detection.
2026-07
Latus Bio
Latus Bio Appoints Bethany Mancilla as Chief Business Officer
Latus Bio announced the appointment of Bethany Mancilla as Chief Business Officer. The company also has publications on optimized AAV capsids for basal ganglia diseases.
2026-06
BioSpace
Cerevance Completes Enrollment in Pivotal Phase 3 Parkinson's Disease Trial and Closes Oversubscribed $20 Million Series C to Extend Runway into 2027
Cerevance completed enrollment in its Phase 3 ARISE trial for Parkinson's disease and closed a $20 million Series C funding round. The trial evaluates solengepras, a non-dopaminergic therapy targeting the GPR6 receptor to reduce OFF periods by balancing basal ganglia pathways.
2026-05
Tiziana Life Sciences Ltd.
Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab
Tiziana Life Sciences announced initial quantitative PET imaging results from a Phase 2 trial showing reduced brain inflammation, specifically in the basal ganglia and thalamus, in Multiple System Atrophy (MSA) patients treated with intranasal foralumab.
2026-05
ScienceDaily
Doctors test brain cell implants to restore movement in Parkinson's
Researchers at Keck Medicine of USC are conducting a clinical trial to implant dopamine-producing stem cells into the basal ganglia to restore motor function in Parkinson's patients. The stem cell therapy, RNDP-001 by Kenai Therapeutics, has fast-track designation from the FDA.
2026-02
PLOS Biology
Basal ganglia components have distinct computational roles in decision-making dynamics under conflict and uncertainty
A research article published in PLOS Biology investigates the distinct computational roles of basal ganglia structures in decision-making under conflict and uncertainty, utilizing neural recordings from human basal ganglia areas.
2025-01

Frequently Asked Questions

Basal Ganglia's AI products are designed to optimize clinical decision-making, automate administrative tasks, and enhance diagnostic accuracy, ultimately leading to improved patient outcomes and operational efficiencies. Our solutions leverage advanced machine learning to provide actionable insights, reducing physician burnout and allowing more time for direct patient interaction.
Basal Ganglia is committed to stringent regulatory compliance, including HIPAA, GDPR, and FDA guidelines for medical devices where applicable, ensuring the highest standards of data privacy and security. We also adhere to ethical AI principles, focusing on transparency, fairness, and accountability in our algorithms to build trust within the healthcare community.
Our pricing model is typically subscription-based, tailored to the size and specific needs of each healthcare organization, often based on user count or modules deployed. We strive for transparency, providing clear breakdowns of all costs upfront with no hidden fees, and offer various tiers to accommodate different budgetary requirements.
Basal Ganglia offers comprehensive technical support, including 24/7 access to our expert team, dedicated account managers, and extensive online resources. We also provide robust training programs for clinical and administrative staff to ensure seamless integration and maximize the value derived from our AI solutions.
Yes, Basal Ganglia prioritizes seamless integration with major EHR systems like Epic, Cerner, and Meditech through standard APIs and custom integrations. Our partnership models range from direct licensing to collaborative development, focusing on creating synergistic relationships that drive innovation and address specific healthcare challenges.
Basal Ganglia is backed by strong investor support and a clear long-term roadmap focused on continuous innovation in healthcare AI. Our commitment to research and development, coupled with a growing client base, ensures our financial stability and capacity to provide ongoing support and future enhancements to our platforms.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.